Abstract
An improved and scalable process for the production of rivastigmine tartrate is reported. The improved process provides rivastigmine tartrate at considerably lower cost and allows the omission of hazardous chemicals. The overall yield is increased from 4.66% (reported process) to 17% with the improved process.
Keywords: Rivastigmine tartrate, a cholinesterase inhibitor, alzheimer's disease, improved process, impurities
Letters in Organic Chemistry
Title: An Improved Process for the Production of Rivastigmine Tartrate, a Cholinesterase Inhibitor
Volume: 7 Issue: 2
Author(s): Vajrala Venkata Reddy, Mandava Venkata Naga Brahmeswara Rao, Varanasi Ganesh, Adla Vijaya Kumar, Cherukupally Praveen, Khagga Mukkanti, Ganta Mahesh Reddy and Ganta Madhusudhan Reddy
Affiliation:
Keywords: Rivastigmine tartrate, a cholinesterase inhibitor, alzheimer's disease, improved process, impurities
Abstract: An improved and scalable process for the production of rivastigmine tartrate is reported. The improved process provides rivastigmine tartrate at considerably lower cost and allows the omission of hazardous chemicals. The overall yield is increased from 4.66% (reported process) to 17% with the improved process.
Export Options
About this article
Cite this article as:
Reddy Venkata Vajrala, Naga Brahmeswara Rao Venkata Mandava, Ganesh Varanasi, Kumar Vijaya Adla, Praveen Cherukupally, Mukkanti Khagga, Reddy Mahesh Ganta and Reddy Madhusudhan Ganta, An Improved Process for the Production of Rivastigmine Tartrate, a Cholinesterase Inhibitor, Letters in Organic Chemistry 2010; 7 (2) . https://dx.doi.org/10.2174/157017810790796246
DOI https://dx.doi.org/10.2174/157017810790796246 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-Cholinergic Pharmacotherapy Approaches to Alzheimers Disease: The Use of Non-Steroidal Anti-Inflammatory Drugs
CNS & Neurological Disorders - Drug Targets Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimers Disease
Current Topics in Medicinal Chemistry Electroacupuncture Ameliorates CUMS-induced Depression-like Behavior: Involvement of the Glutamatergic System and Apoptosis in Rats
Combinatorial Chemistry & High Throughput Screening The Neural Basis of Three Elements in Language Processing: A Review of Neuroimaging Studies
Neuroscience and Biomedical Engineering (Discontinued) Chemistry and Biology of Thyrotropin-Releasing Hormone (TRH) and its Analogs
Current Medicinal Chemistry New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
Current Pharmaceutical Design Cognitive Effects of Nicotine: Recent Progress
Current Neuropharmacology Wnt Signaling in Development, Disease and Translational Medicine
Current Drug Targets The Role of Innate Immune System Receptors in Epilepsy Research
CNS & Neurological Disorders - Drug Targets Graphical Abstracts
Current Pharmaceutical Analysis The Host Complement System and Arbovirus Pathogenesis
Current Drug Targets Drug Repositioning Through Network Pharmacology
Current Topics in Medicinal Chemistry Early Tau Pathology Involving the Septo-Hippocampal Pathway in a Tau Transgenic Model: Relevance to Alzheimers Disease
Current Alzheimer Research The Role of Oxytocin in Autism Spectrum Disorders
Current Psychopharmacology Memory Deficits Correlating with Acetylcholinesterase Splice Shift and Amyloid Burden in Doubly Transgenic Mice
Current Alzheimer Research Solid Nanoemulsion Preconcentrate (NanOsorb) for Oral Delivery of Sertraline: Development and Characterization
Drug Delivery Letters Long-term Potentiation at Spinal C-fiber Synapses: A Target for Pathological Pain
Current Pharmaceutical Design Genetic Variation Underlying Psychosis-inducing Effects of Cannabis: Critical Review and Future Directions
Current Pharmaceutical Design Promises of Nanotechnology for Drug Delivery to Brain in Neurodegenerative Diseases
Current Nanoscience Heme Oxygenase-1 against Vascular Insufficiency: Roles of Atherosclerotic Disorders
Current Pharmaceutical Design